Outcome Study of Conventional Steroids vs. Steroids Combined With Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.
Immune thrombocytopenia Purpura (ITP) is an autoimmune condition delineated by humoral as well as cell mediated immune response against thrombocyte surface proteins GPIIb/IIIa receptors, affecting primary homeostasis leading to mucocutaneous bleeding.ITP is characterized by platelet count <100 x 109/L. The conventional line of treatment for newly diagnosed ITP is steroids but significant disadvantages have been associated with long term use and a high risk of relapse when reducing the dose. The addition of MMF to the first line treatment of ITP resulted in substantial response and a lower risk of refractory ITP with decreased financial burden and improved outcome.
- EligibilityCriteria: Inclusion Criteria:  Age:5-60years Platelet count<30x109  Exclusion Criteria:  Pregnancy Lactation h/o hepatitis B and C HIV reactive patients allergic to drug - HealthyVolunteers: No - Gender: All - MinimumAge: 5 Years - MaximumAge: 60 Years - StdAgeList: Child, Adult